MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer
Not Applicable
Terminated
- Conditions
- Head and Neck CancerRadiation ToxicityXerostomia
- First Posted Date
- 2008-02-25
- Last Posted Date
- 2016-04-19
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 30
- Registration Number
- NCT00623129
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
CD-NP in Subjects With Stable Chronic Heart Failure
- First Posted Date
- 2008-02-21
- Last Posted Date
- 2012-09-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 19
- Registration Number
- NCT00620308
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2008-02-21
- Last Posted Date
- 2014-08-01
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 969
- Registration Number
- NCT00620373
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Molecular Breast Imaging in Women With Atypia and LCIS
Not Applicable
Completed
- Conditions
- Atypical Lobular HyperplasiaLobular Carcinoma in SituAtypical Ductal Hyperplasia
- Interventions
- Procedure: Molecular Breast ImagingProcedure: Screening Mammography
- First Posted Date
- 2008-02-21
- Last Posted Date
- 2016-10-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 66
- Registration Number
- NCT00620087
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2008-02-20
- Last Posted Date
- 2011-05-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 35
- Registration Number
- NCT00618345
Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2011-05-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 15
- Registration Number
- NCT00616720
Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 927
- Registration Number
- NCT00613470
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Studying the Effect of Freeze-Dried Table Grape Powder on Blood Estrogen Levels in Postmenopausal Women
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2008-02-08
- Last Posted Date
- 2019-04-08
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT00611104
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 63
- Registration Number
- NCT00609167
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇨🇦Princess Margaret Hospital, Toronto, Ontario, Canada
Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy
Phase 2
Completed
- Conditions
- Vascular Access Device ComplicationsUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Procedure: vascular access device placement
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2014-05-09
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 100
- Registration Number
- NCT00607880
- Locations
- 🇺🇸
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath